Safety of High flow nasal cannula oxygen for COVID-19
A. Rokach (Jerusalem, Israel), O. Perez (Jerusalem, Israel), M. Shitrit (Jerusalem, Israel), M. Ouaknin (Jerusalem, Israel), P. Levin (Jerusalem, Israel)
Source: Respiratory Failure and Mechanical Ventilation Conference 2022 - Opening session: Essentials of respiratory physiology - Assessment of respiratory muscle function - Pulmonary infections in mechanically ventilated patients - Telemonitoring of patients with chronic respiratory failure - Diagnostics and interventions - Acute respiratory failure: COVID-19 - Interstitial lung disease and pulmonary hypertension - Early rehabilitation - Acute respiratory failure: Invasive mechanical ventilation - HFNO and NIV for acute hypoxemic failure
Session: HFNO and NIV for acute hypoxemic failure
Session type: Oral poster discussion
Number: 47
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rokach (Jerusalem, Israel), O. Perez (Jerusalem, Israel), M. Shitrit (Jerusalem, Israel), M. Ouaknin (Jerusalem, Israel), P. Levin (Jerusalem, Israel). Safety of High flow nasal cannula oxygen for COVID-19. Respiratory Failure and Mechanical Ventilation Conference 2022 - Opening session: Essentials of respiratory physiology - Assessment of respiratory muscle function - Pulmonary infections in mechanically ventilated patients - Telemonitoring of patients with chronic respiratory failure - Diagnostics and interventions - Acute respiratory failure: COVID-19 - Interstitial lung disease and pulmonary hypertension - Early rehabilitation - Acute respiratory failure: Invasive mechanical ventilation - HFNO and NIV for acute hypoxemic failure
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|